Bluejay Diagnostics, Inc. (BJDX)

Bluejay Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5.76	2.21	10.11	19.05	0.91	0.1
Cash & Short-Term Investments	5.76	2.21	10.11	19.05	0.91	0.1
Cash Growth	13.37%	-78.17%	-46.90%	1987.75%	850.27%	-
Other Receivables	-	-	-	-	-	0
Receivables	-	-	-	-	-	0
Inventory	-	-	-	-	0.08	0.12
Prepaid Expenses	0.81	0.75	1.67	1.61	0.06	0.01
Other Current Assets	-	0.27	-	-	-	0.07
Total Current Assets	6.57	3.22	11.79	20.66	1.06	0.3
Property, Plant & Equipment	1.76	1.62	1.7	0.34	0.46	0.62
Other Long-Term Assets	0.02	0.03	0.04	0.02	-	-
Total Assets	8.35	4.87	13.52	21.02	1.52	0.92
Accounts Payable	0.32	0.49	0.64	0.3	0.37	0.03
Accrued Expenses	0.62	1.11	0.83	0.34	0.13	-
Short-Term Debt	-	-	-	-	0.01	-
Current Portion of Long-Term Debt	-	-	-	-	1.04	0.27
Current Portion of Leases	0.12	0.17	0.17	-	-	-
Other Current Liabilities	-	-	-	-	0.28	0.28
Total Current Liabilities	1.05	1.77	1.64	0.64	1.85	0.58
Long-Term Debt	-	-	-	-	-	0.8
Long-Term Leases	0.14	0.2	0.34	-	-	-
Total Liabilities	1.19	1.97	1.98	0.64	1.85	1.38
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	40.4	29.85	28.54	28.07	-	-
Retained Earnings	-33.24	-26.95	-17	-7.69	-4.21	-2.93
Total Common Equity	7.16	2.89	11.54	20.38	-4.21	-2.93
Shareholders' Equity	7.16	2.89	11.54	20.38	-0.33	-0.46
Total Liabilities & Equity	8.35	4.87	13.52	21.02	1.52	0.92
Total Debt	0.26	0.37	0.51	-	1.06	1.07
Net Cash (Debt)	5.5	1.84	9.6	19.05	-0.14	-0.97
Net Cash Growth	17.77%	-80.85%	-49.59%	-	-	-
Working Capital	5.52	1.45	10.15	20.02	-0.79	-0.28
Tangible Book Value	7.16	2.89	11.54	20.38	-4.21	-2.93
Machinery	1.43	1.43	1.41	0.77	0.76	0.76
Construction In Progress	1.36	1.05	0.38	0.02	-	-
Leasehold Improvements	0.04	0.04	0.04	-	-	-

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q